Key Details
Price
$1.71PE Ratio
2.59Annual ROE
0.84%Beta
1.01Events Calendar
Next earnings date:
Dec 13, 2024Recent quarterly earnings:
Sept 17, 2024Recent annual earnings:
July 11, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
July 12, 2021Analyst ratings
Recent major analysts updates
08 Nov '21 HC Wainwright & Co.
NeutralMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
PharmaCyte Biotech doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
FAQ
- What is the primary business of PharmaCyte Biotech?
- What is the ticker symbol for PharmaCyte Biotech?
- Does PharmaCyte Biotech pay dividends?
- What sector is PharmaCyte Biotech in?
- What industry is PharmaCyte Biotech in?
- What country is PharmaCyte Biotech based in?
- When did PharmaCyte Biotech go public?
- Is PharmaCyte Biotech in the S&P 500?
- Is PharmaCyte Biotech in the NASDAQ 100?
- Is PharmaCyte Biotech in the Dow Jones?
- When was PharmaCyte Biotech's last earnings report?
- When does PharmaCyte Biotech report earnings?
- Should I buy PharmaCyte Biotech stock now?
What is the primary business of PharmaCyte Biotech?
PharmaCyte Biotech is a biotechnology company focused on developing innovative treatments for cancer and other diseases. They use a unique cell-based therapy platform to create targeted therapies, aiming to improve patient outcomes and reduce side effects compared to traditional treatments.
What is the ticker symbol for PharmaCyte Biotech?
The ticker symbol for PharmaCyte Biotech is NASDAQ:PMCB
Does PharmaCyte Biotech pay dividends?
No, PharmaCyte Biotech does not pay dividends
What sector is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Healthcare sector
What industry is PharmaCyte Biotech in?
PharmaCyte Biotech is in the Biotechnology industry
What country is PharmaCyte Biotech based in?
PharmaCyte Biotech is headquartered in United States
When did PharmaCyte Biotech go public?
PharmaCyte Biotech's initial public offering (IPO) was on 02 January 2013
Is PharmaCyte Biotech in the S&P 500?
No, PharmaCyte Biotech is not included in the S&P 500 index
Is PharmaCyte Biotech in the NASDAQ 100?
No, PharmaCyte Biotech is not included in the NASDAQ 100 index
Is PharmaCyte Biotech in the Dow Jones?
No, PharmaCyte Biotech is not included in the Dow Jones index
When was PharmaCyte Biotech's last earnings report?
PharmaCyte Biotech's most recent earnings report was on 17 September 2024
When does PharmaCyte Biotech report earnings?
The next expected earnings date for PharmaCyte Biotech is 13 December 2024
Should I buy PharmaCyte Biotech stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions